Skip to content

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.

Maria Lara Porpino de Meiroz Grilo, Geovan Menezes de Sousa, Lilían Andrade Carlos de Mendonça, Bruno Lobão-Soares, Maria Bernardete Cordeiro de Sousa, Fernanda Palhano-Fontes, Draulio Barros de Araujo, Daniel Perkins, Jaime Eduardo Cecilio Hallak, Nicole Leite Galvão-Coelho

Frontiers in behavioral neuroscience January 1, 2022 DOI: 10.3389/fnbeh.2022.901425 via PubMed

Summary

AI-generated from the abstract

Repeated ayahuasca administration before and during social isolation prevented depressive-like behaviors and cortisol alterations in common marmosets. Animals given ayahuasca showed higher cortisol reactivity and fecal cortisol levels similar to family-group controls, no signs of anhedonia, and no increase in chronic stress-related behaviors, unlike isolated animals that received no intervention. The findings suggest ayahuasca promotes resilient responses and may have a prophylactic action against depression.

Study at a glance

Characteristics Experimental study Peer reviewed
Sample size 18
Population Juvenile common marmosets (Callithrix jacchus)
Intervention Ayahuasca
Dose 1.67 mL/300g body weight
Duration 12 weeks
Topics Ayahuasca DMT
Keywords Callithrix jacchus Depression model Resilience Ayahuasca psychedelic brew
Citations 12
Key finding Ayahuasca administration before and during social isolation prevented depressive-like behaviors and cortisol alterations in marmosets, suggesting a prophylactic effect against depression.

Abstract

Observational studies of long-term users of ayahuasca, an Amazonian psychedelic brew, suggest an increase in resilience via improvements in emotion and cognition. Ayahuasca has also demonstrated clinical antidepressant effects in human and animal studies; however, its potential prophylactic action in depression has not been previously studied. Therefore, this experimental study sought to evaluate the potential prophylactic effects of repeated and long-term ayahuasca use, via the modulation of resilience, in a non-human primate animal model, Callithrix jacchus, subjected to a protocol for induction of depressive-like behavior. For the formation of the study groups, some juvenile marmosets were kept in their family groups (GF = 7), while for the two experimental groups, the animals were removed from the family and kept socially isolated. Then, part of the isolated animals made up the group in which ayahuasca was administered (AG, n = 6), while for others, no intervention was made (IG, n = 5). AG animals took ayahuasca (1.67 mL/300g body weight) at weeks 4 (before isolation), 8, and 12 (during isolation) of the study. More adaptive stress response was observed for the AG when compared to the IG. The AG showed higher cortisol reactivity and fecal cortisol levels than IG, while both measures were similar to FG. Moreover, AG animals showed no signs of anhedonia and no increase in chronic stress-related behaviors, which were expressed by the IG. Thus, ayahuasca seems to promote the expression of resilient responses, indicating a prophylactic action, buffering the emergence of depressive-like behaviors and cortisol alterations associated with major depression. These results are encouraging for further research on the prophylactic use of psychedelics to prevent psychopathologies associated with chronic stress.

Explore topics

Comments

No comments yet.

Log in to comment